CT-guided irreversible electroporation safe in unresectable pancreatic carcinoma

A small group of patients with locally advanced unresectable pancreatic carcinoma suffered no major ill effects—pancreatitis or fistula formation—after undergoing percutaneous CT-guided irreversible electroporation (IRE)—a nonthermal ablation technology that is safe near vascular and ductal structures—as a therapy.

"Our findings exceeded our expectations," said Maria Paola Belfiore, a researcher at the Institute of Radiology, Second University of Naples. "In fact, three patients were downstaged, and so had a greater life expectancy. This is a great new promise for inoperable tumors."

The ablation procedure was successful in 100 percent of the patients. These early results represent a good alternative to intraoperative IRE , and offer a safe and feasible primary local treatment for locally advanced pancreatic cancer.


Explore further

Electrical pulse treatment gives pancreatic cancer patients new hope

More information: Dr. Belfiore presented the study on May 6 at the 2014 ARRS Annual Meeting in San Diego, CA.
Citation: CT-guided irreversible electroporation safe in unresectable pancreatic carcinoma (2014, May 7) retrieved 27 January 2021 from https://medicalxpress.com/news/2014-05-ct-guided-irreversible-electroporation-safe-unresectable.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments